CEL-SCI Stock (AMEX: CVM) stock price, news, charts, stock research, profile.
Open | $1.650 |
Close | $1.420 |
Volume / Avg. | 398.163K / 375.998K |
Day Range | 1.420 - 1.660 |
52 Wk Range | 1.040 - 3.230 |
Market Cap | $76.651M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 41 |
Short Interest | 13.04% |
Days to Cover | 36.2 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CEL-SCI (AMEX: CVM) through any online brokerage.
Other companies in CEL-SCI’s space includes: Anixa Biosciences (NASDAQ:ANIX), HOOKIPA Pharma (NASDAQ:HOOK), Connect Biopharma Hldgs (NASDAQ:CNTB), Burning Rock Biotech (NASDAQ:BNR) and Barinthus Biotherapeutics (NASDAQ:BRNS).
The latest price target for CEL-SCI (AMEX: CVM) was reported by EF Hutton on Wednesday, July 12, 2023. The analyst firm set a price target for 10.00 expecting CVM to rise to within 12 months (a possible 604.23% upside). 1 analyst firms have reported ratings in the last year.
The stock price for CEL-SCI (AMEX: CVM) is $1.42 last updated May 10, 2024 at 8:00 PM EDT.
There are no upcoming dividends for CEL-SCI.
CEL-SCI’s Q3 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for CEL-SCI.
CEL-SCI is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.